Rekvio subcutaneous injection 300mg syringe (YJ_code: 2189403G1029, standard: 300mg1.5mL1 tube), manufactured by Novartis Pharma, contains Inclisiran sodium. It is a small interfering RNA (siRNA) therapy used to lower low-density lipoprotein cholesterol (LDL-C) levels, particularly for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, or established atherosclerotic cardiovascular disease.
Rekvio subcutaneous injection 300mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).